Clinical Trials · NCT00003124

Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer

CompletedPhase 2Gonadorelin (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Herbert Irving Comprehensive Cancer Center
Enrollment
105
Start date
May 1997
Locations
1 site, United States
Primary endpoint
Study in Prostate Cancer
View Gonadorelin compound reference